Martin Leclerc

Martin Leclerc appears in our data through filings on Prometic Life Sciences Inc. shares, published by SEDI. In total, 11 filings cover trades dated from 15 May 2017 to 5 July 2019.

The open-market record is one-sided, with 4 purchases worth €40k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The median purchase comes to €10k. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The latest filing, published on 5 August 2019, reports a transaction in Prometic Life Sciences Inc. The last insider purchase was made public on 23 May 2018, 3,077 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 31 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.